Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 9.749.386.306.235.12

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.74 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20259.74
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 9.74
3.84
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹923.0 Cr -3.7% -2.5% -39.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,773.0 Cr -3.6% -6.8% -5.6% Stock Analytics
DIVIS LABORATORIES ₹159,540.0 Cr -5.4% -2.4% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,529.0 Cr 3.6% 8.5% 23.5% Stock Analytics
CIPLA ₹111,299.0 Cr -5.1% -7.1% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹97,393.0 Cr -4.1% -8.3% -12.1% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-3.7%

-2.5%

-39.3%

SENSEX

-2%

-2.8%

7.4%


You may also like the below Video Courses